Assessment of direct-acting oral anticoagulants for the treatment of venous thromboembolism in cancer patients in Thai Tertiary Care Hospital
Venous thromboembolism (VTE) is an important cancer complication. Recent studies suggest direct-acting oral anticoagulants (DOACs) are possible alternatives for this population; nonetheless, there is limited evidence to support this decision in Thai cancer patients. The primary aim of this study was...
Saved in:
Main Authors: | Jennis Meanwatthana (Author), Phatcharin Mitsuntisuk (Author) |
---|---|
Format: | Book |
Published: |
Faculty of Pharmacy, Mahidol University,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
by: К. V. Lobastov, et al.
Published: (2020) -
The current place of direct oral anticoagulants in the prevention/treatment of venous thromboembolism
by: Tomić Maja
Published: (2020) -
Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
by: Maha Al-Ghafry, et al.
Published: (2022) -
New anticoagulants for the prevention of venous thromboembolism
by: Cecilia Becattini, et al.
Published: (2010) -
Anticoagulant therapy for acute venous thromboembolism
by: Hilal Ermiş, et al.
Published: (2017)